Cargando…

Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy

There is an increasing worldwide incidence of patients under 50 years of age presenting with oral squamous cell carcinoma (OSCC). The molecular mechanisms driving disease in this emerging cohort remain unclear, limiting impactful treatment options for these patients. To identify common clinically ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satgunaseelan, Laveniya, Porazinski, Sean, Strbenac, Dario, Istadi, Aji, Willet, Cali, Chew, Tracy, Sadsad, Rosemarie, Palme, Carsten E., Lee, Jenny H., Boyer, Michael, Yang, Jean Y. H., Clark, Jonathan R., Pajic, Marina, Gupta, Ruta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666981/ https://www.ncbi.nlm.nih.gov/pubmed/34912708 http://dx.doi.org/10.3389/fonc.2021.750852

Ejemplares similares

Whole genome duplication in oral squamous cell carcinoma in patients younger than 50 years: implications for prognosis and adverse clinicopathological factors
por: Satgunaseelan, Laveniya, et al.
Publicado: (2022)

Viral Integration Plays a Minor Role in the Development and Prognostication of Oral Squamous Cell Carcinoma
por: Satgunaseelan, Laveniya, et al.
Publicado: (2022)

Elemental bioimaging shows mercury and other toxic metals in normal breast tissue and in breast cancers
por: Pamphlett, Roger, et al.
Publicado: (2020)

“MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report”
por: Yabe, Takako Eva, et al.
Publicado: (2022)

A CRISPR Path to Finding Vulnerabilities and Solving Drug Resistance: Targeting the Diverse Cancer Landscape and Its Ecosystem
por: McLean, Benjamin, et al.
Publicado: (2022)

Hemorrhagic Meningitis Due to Varicella-Zoster Virus: A Case Report With Clinical, Cytologic, and Radiologic Correlation
por: Gorolay, Vineet, et al.
Publicado: (2022)

Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics
por: Tűzesi, Ágota, et al.
Publicado: (2023)

Genomic Characterization of External Morphology Traits in Kelpies Does Not Support Common Ancestry with the Australian Dingo
por: Chew, Tracy, et al.
Publicado: (2019)

Development of the oral resistome during the first decade of life
por: Sukumar, Smitha, et al.
Publicado: (2023)

Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers
por: Gong, Tingting, et al.
Publicado: (2022)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy
por: Seki, Nobuhiko, et al.
Publicado: (2019)

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023)

Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma—A Case Report and Systematic Review
por: Yuile, Alexander, et al.
Publicado: (2022)

A computable biomedical knowledge object for calculating in‐hospital mortality for patients admitted with acute myocardial infarction
por: Sadsad, Rosemarie, et al.
Publicado: (2023)

Low‐grade BRAF V600E mutant oligodendroglioma‐like tumors of children may show EGFR and MET amplification
por: Yang, Rui Ryan, et al.
Publicado: (2020)

EGFR Amplification and Glioblastoma Stem-Like Cells
por: Liffers, Katrin, et al.
Publicado: (2015)

A Coding Variant in the Gene Bardet-Biedl Syndrome 4 (BBS4) Is Associated with a Novel Form of Canine Progressive Retinal Atrophy
por: Chew, Tracy, et al.
Publicado: (2017)

African-specific molecular taxonomy of prostate cancer
por: Jaratlerdsiri, Weerachai, et al.
Publicado: (2022)

Effectiveness of Hospital-Wide Methicillin-Resistant Staphylococcus aureus (MRSA) Infection Control Policies Differs by Ward Specialty
por: Sadsad, Rosemarie, et al.
Publicado: (2013)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma
por: Richard, Corentin, et al.
Publicado: (2018)

Defining EGFR amplification status for clinical trial inclusion
por: French, Pim J, et al.
Publicado: (2019)

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Hu, Leland S., et al.
Publicado: (2021)

Rolling circle amplification shows a sinusoidal template length-dependent amplification bias
por: Joffroy, Bastian, et al.
Publicado: (2018)

HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs
por: Watanabe, Sho, et al.
Publicado: (2021)

Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis
por: Ebrahimkhani, Saeideh, et al.
Publicado: (2018)

Reaction rate law model and reaction mechanism covering effect of plasma role on the transesterification of triglyceride and methanol to biodiesel over a continuous flow hybrid catalytic-plasma reactor
por: Purwanto, P., et al.
Publicado: (2020)

Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast
por: Agelopoulos, Konstantin, et al.
Publicado: (2007)

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco
por: Senhaji, Nadia, et al.
Publicado: (2017)

Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification
por: Dekanić, Andrea, et al.
Publicado: (2011)

Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
por: Porazinski, Sean, et al.
Publicado: (2018)

EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Sesboüé, R, et al.
Publicado: (2012)

Heterogeneity of resistant mechanisms in an EGFR-TKI relapsed patient with EGFR amplification and response to nimotuzumab: A case report
por: Li, Yan, et al.
Publicado: (2022)

Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
por: Peters, T. L., et al.
Publicado: (2021)

EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
por: Hwangbo, Won, et al.
Publicado: (2013)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status
por: Dhawan, Andrew, et al.
Publicado: (2023)

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target
por: Iida, K, et al.
Publicado: (2011)

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Ålgars, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_spg7e06k4olt66n49fb6i8ekk1